Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most?
Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK. Electronic address: e.cole@qmul.ac.uk.
Elaine
E
Cole
Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK.
Ross
R
Davenport
D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005340:Fibrinogen / Q000502:physiology*; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D014148:Tranexamic Acid / Q000494:pharmacology / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D005340:Fibrinogen